POU4F3 and SLC17A8 Deafness Genetic Testing Study

Terminated prospective observational study using blood-sample genetic analysis to estimate POU4F3 and SLC17A8 mutation prevalence in familial autosomal dominant deafness.

ClinicalTrials.gov verifies a terminated observational genetic-testing study. The generated row was previously misleading as a therapeutic gene-therapy record; it is now normalized as a diagnostic study and not a treatment program.